Knowledge Beyond the Deal Table.
Beyond the deal table, we apply the same rigor to engagements that sit at the boundary of finance, science, and institutional governance. Our strategic advisory practice serves early-stage biotech ventures, academic research initiatives, non-profit organizations, and professionals navigating complex career transitions in banking and the life sciences. Each engagement draws on a rare combination of transaction experience and active academic research.
Life Science Venture Screening
Commercial-scientific assessment of early-stage biotech opportunities. IP evaluation, technology readiness, and transaction structuring.
Salvany Partners delivers research-informed, AI-powered perspectives on what your technology is worth and how to capitalize on it — surfacing IP-value drivers that conventional due diligence misses.
Academic & Scientific Writing
Research design, editorial support, and co-authorship in biotech strategy and transaction management, grounded in modern entrepreneurship and innovation theory.
Guest lectures and speaking roles can be booked on request. Other topics of relevance include complexity/cybernetics, especially systemic collapse theory.
Institutional & Community Advisory
Strategic governance, financial planning, and organizational development for foundations, non-profits, and charity institutions.
Through long-standing and close cooperation with Catholic charities, Salvany Partners assists you in any philanthropic venture you engage in.
Executive Education & Mentoring
Career strategy for professionals entering or advancing in investment banking, corporate finance, and the life sciences sector.
In particular, Salvany Partners offers advice to Indian young professionals seeking to study and work in Frankfurt and Germany in general.
EU Market Entry & ESG Advisory
Our Lisbon partner BridgeIt Europe delivers full-spectrum solutions for EU internationalization, ESG compliance, and SME digitalization. By providing tailored market-entry strategies and comprehensive sustainability reporting aligned with rigorous European regulatory standards, they empower businesses to scale across the Union while maintaining good governance and operational innovation.